{"id":7991,"date":"2020-03-27T16:00:46","date_gmt":"2020-03-27T08:00:46","guid":{"rendered":"http:\/\/web.csh.org.tw\/web\/csh\/?p=7991"},"modified":"2020-10-19T17:20:54","modified_gmt":"2020-10-19T09:20:54","slug":"%e3%80%90%e5%85%ac%e5%91%8a%e3%80%91%e6%9c%ac%e9%99%a2%e5%b0%8f%e5%85%92%e8%a1%80%e6%b6%b2%e8%85%ab%e7%98%a4%e7%a7%91%e6%96%b0%e9%80%b2%e9%86%ab%e5%b8%ab","status":"publish","type":"post","link":"https:\/\/web.csh.org.tw\/web\/csh\/?p=7991","title":{"rendered":"\u3010\u516c\u544a\u3011\u672c\u9662\u5c0f\u5152\u8840\u6db2\u816b\u7624\u79d1\u65b0\u9032\u91ab\u5e2b\uff0d\u5deb\u5eb7\u7199\u91ab\u5e2b"},"content":{"rendered":"

\u5deb\u5eb7\u7199\u91ab\u5e2b<\/strong> (<\/strong>\u65bc<\/strong>4<\/strong>\u6708\u4efd\u65bc\u672c\u9662\u670d\u52d9<\/strong>)<\/strong>\"1090309\"<\/a><\/p>\n

\u00a0<\/p>\n\n\n

\u73fe\u4efb<\/strong><\/strong><\/p>\n\n\n\n

  1. \u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u526f\u9662\u9577<\/li>
  2. \u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u91ab\u5b78\u7cfb \u6559\u6388<\/li>
  3. \u53f0\u7063\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5b78\u6703 \u6307\u5c0e\u91ab\u5e2b <\/li>
  4. \u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u75c5\u5b78\u6703 \u6307\u5c0e\u91ab\u5e2b<\/li>
  5. \u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u5b78 \u59d4\u54e1<\/li>
  6. \u4e2d\u83ef\u6c11\u570b\u5152\u7ae5\u764c\u75c7\u57fa\u91d1\u6703 \u5b78\u8853\u5c0f\u7d44\u59d4\u54e1\u6703 \u59d4\u54e1<\/li>
  7. \u4e2d\u83ef\u6c11\u570b\u5152\u7ae5\u764c\u75c7\u57fa\u91d1\u6703 \u53f0\u7063\u5152\u7ae5\u764c\u75c7\u7814\u7a76\u7fa4 \u9867\u554f\u91ab\u5e2b<\/li>
  8. \u53f0\u7063\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5b78\u6703 \u5c08\u79d1\u91ab\u5e2b\u7504\u5be9\u59d4\u54e1\u6703\/\u7de8\u8f2f\u59d4\u54e1\u6703 \u59d4\u54e1<\/li>
  9. \u81fa\u7063\u4e2d\u897f\u6574\u5408\u91ab\u5b78\u6703 \u7406\u4e8b<\/li>
  10. \u53f0\u7063\u6d77\u6d0b\u6027\u8ca7\u8840\u5354\u6703 \u9867\u554f\u91ab\u5e2b<\/li>
  11. \u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5b78\u8853\u7bc0\u76ee\u59d4\u54e1\u6703 \u59d4\u54e1<\/li>
  12. \u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5152\u79d1\u6700\u524d\u7dda\u96dc\u8a8c \u57f7\u884c\u4e3b\u7de8<\/li><\/ol>\n\n\n\n

    \u5c08\u9577<\/strong><\/strong><\/p>\n\n\n\n

    1. \u5152\u7ae5\u60e1\u6027\u53ca\u826f\u6027\u816b\u7624 (\u5305\u62ec\u4e0d\u660e\u816b\u584a\/\u816b\u7624\u3001\u8840\u7ba1\u7624)<\/li>
    2. \u8840\u6db2\u75be\u75c5 (\u5305\u62ec\u8ca7\u8840\u3001\u7d2b\u6591\u75c7\u3001\u767d\u8840\u7403\u904e\u9ad8\/\u904e\u4f4e)<\/li>
    3. \u5c0f\u5152\u75be\u75c5 (\u5305\u62ec\u4e0d\u660e\u539f\u56e0\u767c\u71d2)<\/li>
    4. \u9aa8\u9ad3\u79fb\u690d (\u5305\u62ec\u81cd\u5e36\u8840\u79fb\u690d\u3001\u5468\u908a\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d\u9aa8\u9ad3\u79fb\u690d)<\/li>
    5. \u5e79\u7d30\u80de\u8f49\u8b6f\u91ab\u5b78<\/li><\/ol>\n\n\n\n

      \u5c08\u79d1\u91ab\u5e2b<\/strong><\/strong><\/p>\n\n\n\n

      1. \u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703\u5152\u79d1\u5c08\u79d1\u91ab\u5e2b<\/li>
      2. \u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5c08\u79d1\u91ab\u5e2b<\/li>
      3. \u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u75c5\u5c08\u79d1\u91ab\u5e2b<\/li><\/ol>\n\n\n\n

        \u5b78\u6b77<\/strong><\/strong><\/p>\n\n\n\n

        \u4e2d\u570b\u91ab\u85e5\u5927\u5b78 \u91ab\u5b78\u58eb<\/p>\n\n\n\n

        \u6559\u8077<\/strong><\/strong><\/p>\n\n\n\n

        \u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u6559\u6388(\u6559\u5b57\u7b2c141601\u865f\uff1b2014\u5e748\u6708\u8fc4\u4eca)
        \u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u526f\u6559\u6388(\u526f\u5b57\u7b2c040201\u865f\uff1b2010\u5e748\u6708-2014\u5e747\u6708)
        \u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u52a9\u7406\u6559\u6388(\u52a9\u7406\u5b57\u7b2c020163\u865f\uff1b2007\u5e741\u6708-2010\u5e747\u6708)
        \u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u8b1b\u5e2b(\u8b1b\u5b57\u7b2c077537\u865f\uff1b2004\u5e741\u6708-2006\u5e7412\u6708)<\/p>\n\n\n\n

        \u69ae\u8b7d<\/strong>(Honor)<\/strong><\/p>\n\n\n\n

        1. 2008\u5e74\u5546\u696d\u5468\u520a\u767e\u5927\u826f\u91ab\u63a8\u85a6\u597d\u91ab\u5e2b<\/li>
        2. 2012 & 2018\u5e74\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662\u5091\u51fa\u91ab\u5e2b<\/li>
        3. 2003 & 2004\u5e74\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662\u512a\u826f\u91ab\u5e2b<\/li>
        4. \u97d3\u570b\u3001\u8d8a\u5357\u3001\u4e9e\u7f8e\u5c3c\u4e9e\u7b49\u591a\u570b\u91ab\u5e2b\u53f0\u5411\u5deb\u91ab\u5e2b\u5b78\u7fd2<\/li>
        5. 2008~2012\u5e74\u570b\u969b\u6703\u8b70Pan Pacific Symposium on Stem Cells and Cancer Research\u7d44\u7e54\u59d4\u54e1\u6703\u59d4\u54e1<\/li>
        6. \u591a\u6b21\u570b\u969b\u5927\u6703\u61c9\u9080\u6f14\u8b1b\u53ca\u4e3b\u6301\u4eba<\/li>
        7. \u70ba\u570b\u969b\u77e5\u540dSCI\u91ab\u5b78\u671f\u520a\u8ad6\u6587\u5be9\u7a3f\u5b78\u8005(reviewer)<\/li>
        8. \u767c\u8868\u4e0a\u767e\u7bc7\u8ad6\u6587\u65bc\u570b\u969b\u77e5\u540dSCI\u91ab\u5b78\u671f\u520a<\/li>
        9. 12th International\nConference on Oral Chelation in the Treatment of Thalassaemia and Other Diseases\n(2002) \u512a\u826f\u8ad6\u6587\u767c\u8868\u734e<\/li>
        10. \u53f0\u7063\u8840\u6db2\u75c5\u5b78\u67032006\u5e74\u9752\u5e74\u512a\u79c0\u8ad6\u6587\u734e<\/li>
        11. 2019\u5e74\u4e2d\u83ef\u6c11\u570b\u79c1\u7acb\u6559\u80b2\u4e8b\u696d\u6703 \u8cc7\u6df1\u66a8\u512a\u826f\u6559\u5e2b\u734e<\/li>
        12. \u6307\u5c0e\u591a\u4f4d\u78a9\u58eb\u548c\u535a\u58eb\u7562\u696d\uff0c\u4e26\u64d4\u4efb\u591a\u4f4d\u78a9\u58eb\u548c\u535a\u58eb\u53e3\u8a66\u59d4\u54e1<\/li>
        13. \u79d1\u6280\u90e8(\u570b\u79d1\u6703) 2014\u30012015\u30012018\u30012019\u5e74\u8907\u5be9\u6703\u59d4\u54e1<\/li><\/ol>\n\n\n\n

          \u7d93\u6b77<\/strong><\/strong><\/p>\n\n\n\n

          1. \u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1\u4e3b\u4efb<\/li>
          2. \u53f0\u5927\u91ab\u9662\u5152\u79d1\u90e8 \u5c0f\u5152\u8840\u6db2\u816b\u7624\u79d1\u7814\u7a76\u91ab\u5e2b<\/li>
          3. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1\u4e3b\u4efb<\/li>
          4. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u5152\u7ae5\u816b\u7624\u59d4\u54e1\u6703 \u4e3b\u4efb\u59d4\u54e1<\/li>
          5. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u6aa2\u9a57\u91ab\u5b78\u90e8\u8840\u5eab\u4e3b\u4efb<\/li>
          6. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u8840\u6db2\u816b\u7624\u75c5\u623f \u75c5\u623f\u4e3b\u4efb<\/li>
          7. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u7d44\u7e54\u5eab\u66a8\u8840\u6db2\u5e79\u7d30\u80de\u7814\u7a76\u5ba4\u9867\u554f\u91ab\u5e2b<\/li>
          8. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u79fb\u690d\u59d4\u54e1\u6703\/\u8f38\u8840\u59d4\u54e1\u6703\/\u7d44\u7e54\u5eab\u59d4\u54e1\u6703\/\u75c5\u623f\u7ba1\u7406\u59d4\u54e1\u6703\/\u5b89\u5be7\u7642\u8b77\u59d4\u54e1\u6703 \u59d4\u54e1<\/li>
          9. \u4e2d\u570b\u91ab\u85e5\u5927\u5b78 \u5b78\u58eb\u5f8c\u4e2d\u91ab\u5b78\u7cfb \u7cfb\u4e3b\u4efb<\/li>
          10. \u4e2d\u83ef\u6c11\u570b\u95dc\u61f7\u8166\u7624\u5152\u7ae5\u5354\u6703 \u9867\u554f\u91ab\u5e2b<\/li>
          11. \u4e2d\u83ef\u6c11\u570b\u559c\u9858\u5354\u6703 \u9867\u554f\u91ab\u5e2b<\/li>
          12. \u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5c08\u79d1\u91ab\u5e2b\u7504\u9078\u59d4\u54e1\u6703 \u59d4\u54e1<\/li><\/ol>\n\n\n\n

            \u91ab\u5b78\u91cd\u8981\u6210\u5c31<\/strong><\/strong><\/p>\n\n\n\n

            (\u4e00)\u5152\u7ae5\u764c\u75c7: <\/strong>\u5c0d\u5404\u7a2e\u5152\u7ae5\u764c\u75c7\u6709\u5148\u9032\u7684\u6cbb\u7642\u548c\u6df1\u5165\u7684\u7814\u7a76
            1. \u66fe\u520a\u65bc\u4e16\u754c\u9802\u5c16\u671f\u520aJournal of Clinical Oncology (\u767c\u8868\u65bc2002impact factor: 32.956)
            2. \u767c\u73fe\u9ea9\u91af\u80fa\u9178(Glutamine)\u53ef\u986f\u8457\u964d\u4f4e\u767d\u8840\u75c5\u75c5\u7ae5\uff0c\u5728\u4f7f\u7528\u9ad8\u5291\u91cf\u5316\u7642\u85e5MTX\uff0c\u6240\u9020\u6210\u7684\u56b4\u91cd\u53e3\u8154\u6f70\u760d
            3. \u591a\u7bc7\u8840\u764c\u76f8\u95dc\u7814\u7a76\uff0c\u7528\u7b2c\u4e8c\u4ee3\u6a19\u9776\u85e5\uff0c\u6210\u529f\u6cbb\u75ca\u8cbb\u57ce\u67d3\u8272\u9ad4\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\u9aa8\u9ad3\u79fb\u690d\u5f8c\u5fa9\u767c (\u767c\u8868\u65bcPediatr Blood Cancer 2013)
            4. \u767c\u73fe\u4e16\u754c\u7b2c\u4e00\u4f4d\u9670\u8396\u6dcb\u5df4\u764c\u75c5\u7ae5\uff0c\u4e5f\u6210\u529f\u6cbb\u7642\uff0c\u6c92\u6709\u5f8c\u907a\u75c7 (\u767c\u8868\u65bcJ Pediatr Hematol Oncol 2006)
            5. \u548c\u591a\u5bb6\u91ab\u5b78\u4e2d\u5fc3\u5408\u4f5c\uff0c\u767c\u73fe\u8a31\u591a\u8840\u764c\u7684\u76f8\u95dc\u57fa\u56e0\uff0c\u5c0d\u7cbe\u6e96\u91ab\u7642\u5f88\u6709\u52a9\u76ca
            6. \u5c0d\u500b\u7a2e\u5152\u7ae5\u764c\u75c7\uff0c\u8840\u764c\u3001\u6dcb\u5df4\u764c\u3001\uff0c\u795e\u7d93\u6bcd\u7d30\u80de\u764c\u3001\u751f\u6b96\u7d30\u80de\u764c\u3001\u9aa8\u764c\u3001\u862d\u683c\u7f55\u6c0f\u7d44\u7e54\u7d30\u80de\u589e\u591a\u75c7\u3001\u5a01\u723e\u59c6\u6c0f\u7624\u2026.\u7b49\u90fd\u6709SCI\u570b\u969b\u671f\u520a\u767c\u8868<\/p>\n\n\n\n

            (\u4e8c)\u9aa8\u9ad3\u79fb\u690d<\/strong>: \u4e0d\u4f46\u6709\u9ad8\u7684\u6210\u529f\u7387\uff0c\u767c\u8868\u591a\u7bc7\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d\u76f8\u95dc\u7814\u7a76
            1. \u5982\u4f55\u52a0\u901f\u81cd\u5e36\u8840\u79fb\u690d\u9020\u8840\u529f\u80fd\u7684\u6062\u5fa9 (\u767c\u8868\u65bcTransplantation 2013)
            2. \u81ea\u9ad4\u81cd\u5e36\u8840\u79fb\u690d(\u767c\u8868\u65bcBone Marrow Transplant 2013)
            3. \u79fb\u690d\u5f8c\u6392\u65a5\u7684\u6cbb\u7642 (\u767c\u8868\u65bcTransplantation 2011; Medicine 2017)
            4. \u79fb\u690d\u5f8cBK\u75c5\u6bd2\u5f15\u8d77\u51fa\u8840\u6027\u8180\u80f1\u708e\u7684\u6cbb\u7642 (\u767c\u8868\u65bcPediatr Infect Dis J 2014)\uff0c\u4e14\u88ab\u77e5\u540d\u611f\u67d3\u79d1\u6559\u79d1\u66f8\u201d\u71b1\u75c5\u201d\u5f15\u7528
            5. \u9ef4\u83cc\u611f\u67d3\u7684\u8655\u7406 (\u767c\u8868\u65bcPediatrTransplant 2012; Ital J Pediatr 2016
            6. \u570b\u969b\u91ab\u7642\uff0c\u6210\u529f\u9aa8\u9ad3\u79fb\u690d\u6551\u6cbb\u8607\u4e39\u548c\u5370\u5c3c\u75c5\u7ae5<\/p>\n\n\n\n

            (\u4e09)\u8840\u6db2\u75be\u75c5<\/strong> (\u6d77\u6d0b\u6027\u8ca7\u8840\u3001\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u3001\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7\u3001\u8f38\u8840\u91ab\u5b78)
            1. \u6d77\u6d0b\u6027\u8ca7\u8840: \u767c\u8868\u6578\u5341\u7bc7\u6d77\u6d0b\u6027\u8ca7\u8840\u76f8\u95dc\u7814\u7a76\uff0c\u4e0d\u4f46\u81e8\u5e8a\u5e6b\u52a9\u53f0\u7063\u75c5\u60a3\uff0c\u4e5f\u5e6b\u52a9\u76f8\u540c\u75be\u75c5\u7684\u570b\u969b\u75c5\u4eba\u3002\u5408\u4f75\u4f7f\u7528\u6392\u9435\u5291\uff0c\u6210\u529f\u6551\u6cbb\u91cd\u5ea6\u6d77\u6d0b\u6027\u8ca7\u8840\u75c5\u60a3\u7684\u56b4\u91cd\u5fc3\u81df\u4f75\u767c\u75c7\uff0c\u4e0d\u4f46\u5e6b\u52a9\u9019\u6b7b\u4ea1\u7387\u6975\u9ad8\u7684\u554f\u984c\uff0c\u4e5f\u7372\u4e16\u754c\u5f88\u5927\u56de\u97ff (\u767c\u8868\u65bcAnn Hematol 2004; Ann Hematol 2020)
            2. \u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840: \u5f9e\u57fa\u790e\u5230\u6cbb\u7642\uff0c\u767c\u8868\u591a\u7bc7\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u7684\u6df1\u5165\u7814\u7a76\u3002\u4e26\u6df1\u5165\u7814\u7a76\u9593\u8cea\u5e79\u7d30\u80de\u5728\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u7684\u89d2\u8272\uff0c\u4e0d\u4f46\u662f\u9019\u65b9\u9762\u7684pioneer\uff0c\u4e5f\u7372\u4e16\u754c\u80af\u5b9a (\u767c\u8868\u65bcAnnHematol 2010; Pediatr Blood Cancer 2018)
            3. \u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7: \u767c\u73fe\u5152\u7ae5\u514d\u75ab\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7\u548c\u57fa\u56e0\u6709\u95dc\uff0c\u767c\u8868\u65bc\u4e16\u754c\u77e5\u540d\u7684\u671f\u520a (\u767c\u8868\u65bcBr J Haematol 2005)
            4. \u8f38\u8840\u91ab\u5b78: \u767c\u73fe\u53f0\u7063\u7279\u6709\u7684\u7d05\u8840\u7403\u6297\u9ad4\uff0canti-Mia\u6703\u9020\u6210\u56b4\u91cd\u65b0\u751f\u5152\u9ec3\u75b8 (\u4e16\u754c\u7b2c\u4e8c\u4f8b\uff0c\u767c\u8868\u65bcTransfusMed 2002)<\/p>\n\n\n\n

            (\u56db) \u5e79\u7d30\u80de: <\/strong>\u70ba\u9593\u8cea\u5e79\u7d30\u80de\u7814\u7a76\u7684pioneer
            1. \u4e16\u754c\u7b2c\u4e00\u4f4d\u5c07\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u61c9\u7528\u5230\u4eba\u9ad4\u4e0a\uff0c\u8b49\u660e\u5176\u5b89\u5168\u6709\u6548 (\u767c\u8868\u65bcTransplantation2011)
            2. \u5f9e\u57fa\u790e\u5230\u52d5\u7269\uff0c\u61c9\u7528\u5230\u4eba\u9ad4\uff0c\u767c\u8868\u6578\u5341\u7bc7\u9593\u8cea\u5e79\u7d30\u80de\u76f8\u95dc\u7814\u7a76\uff0c\u4e0d\u4f46\u5c0d\u9593\u8cea\u5e79\u7d30\u80de\u7814\u7a76\u5341\u5206\u6df1\u5165\uff0c\u4e5f\u70ba\u5c07\u4f86\u8f49\u8b6f\u91ab\u5b78\u7684\u61c9\u7528\uff0c\u7acb\u4e0b\u5f88\u597d\u7684\u57fa\u790e\u3002
            3. \u767c\u73fe\u9ec3\u8006\u8403\u53d6\u7269(PG2)\u53ef\u52a0\u901f\u9593\u8cea\u5e79\u7d30\u80de\u7684\u751f\u9577\uff0c\u4e26\u52a0\u5f37\u514d\u75ab\u6291\u5236\u6548\u679c (\u767c\u8868\u65bcJ Ethnopharmacol 2017)<\/p>\n\n\n\n

            (\u4e94) \u5c0f\u5152\u79d1\u5b78: <\/strong>\u548c\u5c0f\u5152\u79d1\u91ab\u751f\u5408\u4f5c\uff0c\u767c\u8868\u8a31\u591a\u5152\u79d1\u76f8\u95dc\u7684\u7814\u7a76\uff0c\u5982\u611f\u67d3\uff0c\u514d\u75ab\u529b\u4f4e\u4e0b\uff0c\u6025\u91cd\u75c7..\u7b49<\/p>\n\n\n\n

            \u91ab\u5b78\u8457\u4f5c<\/strong><\/strong><\/p>\n\n\n\n

            1. \u6d77\u6d0b\u6027\u8ca7\u8840\u662f\u4ec0\u9ebc\uff1f(\u51fa\u7248\u793e: \u5408\u8a18\u66f8\u5c40\u6709\u9650\u516c\u53f8<\/a>)<\/li>
            2. \u95dc\u65bc\u5730\u4e2d\u6d77\u578b\u8ca7\u8840 (\u51fa\u7248\u793e: \u85dd\u8ed2\u5716\u66f8\u51fa\u7248\u793e)<\/li><\/ol>\n\n\n\n

              \u5152\u7ae5\u8840\u6db2\u816b\u7624\u75be\u75c5\u5c08\u696d\u7db2\u9801<\/strong><\/strong><\/p>\n\n\n\n

              \u63d0\u4f9b\u6700\u5c08\u696d\u3001\u6b63\u78ba\u3001\u89aa\u6c11\u3001\u5b8c\u6574\u4e14\u5145\u5be6\u7684\u5152\u7ae5\u764c\u75c7\u548c\u8840\u6db2\u75be\u75c5\u8cc7\u8a0a\uff0c\u81f3\u4eca(2020\u5e749\u6708\uff0c\u5df2\u6709593,165\u89c0\u770b\u4eba\u6b21)
              http:\/\/www.onped.com\/hema\/index.php<\/a><\/p>\n\n\n\n

              \u5152\u7ae5\u8840\u6db2\u816b\u7624\u75be\u75c5\u76f8\u95dc<\/strong>YouTube<\/strong><\/p>\n\n\n\n

              1. \u5152\u7ae5\u764c\u75c7\u4ecb\u7d39\u9996\u90e8\u66f2 (\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662)<\/li>
              2. \u5152\u7ae5\u8ca7\u8840\u548c\u8840\u5c0f\u677f\u4f4e\u4e0b\u4ecb\u7d39 (\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662)<\/li>
              3. \u5152\u7ae5\u8840\u7ba1\u7624\u548c\u9aa8\u9ad3\u79fb\u690d\u4ecb\u7d39 (\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662)<\/li>
              4. \u5168\u6c11\u5065\u5eb7\u4fdd\u5065378 (\u552f\u5fc3\u96fb\u8996\u53f0)<\/li>
              5. \u5168\u6c11\u5065\u5eb7\u4fdd\u5065379 (\u552f\u5fc3\u96fb\u8996\u53f0)<\/li>
              6. \u5168\u6c11\u5065\u5eb7\u4fdd\u5065380 (\u552f\u5fc3\u96fb\u8996\u53f0)<\/li><\/ol>\n\n\n\n

                \u76f8\u95dc\u5a92\u9ad4\u5831\u5c0e<\/strong>:<\/strong> (2007-2020)<\/p>\n\n\n\n

                1. \u4e2d\u5c71\u9644\u91ab\u6210\u7acb\u8840\u6db2\u75c5\u4e2d\u5fc3<\/strong> \u60a3\u8005\u4ee5\u6b4c\u8072\u548c\u5409\u4ed6\u6f14\u594f\u795d\u8cc0<\/a> (2020)<\/li>
                2. \u5152\u7ae5\u5b89\u5be7<\/strong>\uff01\u54c8\u97d3\u5c11\u5973\u5370\u624b\u6a21\u7559\u7236\u6bcd\u542b\u7b11\u96e2\u4e16<\/a> (2020)<\/li>
                3. \u5370\u50ad\u5e7c\u5973\u7f79\u8840\u764c<\/strong>\u53f0\u7063\u8001\u95c6\u9019\u9ebc\u505a\u6696\u54ed\u773e\u4eba<\/a> (2020)<\/li>
                4. \u6d77\u6d0b\u6027\u8ca7\u8840<\/strong>\u9577\u671f\u8f38\u8840\u9435\u8cea\u6613\u904e\u91cf\u7d2f\u7a4d \u91ab\u5b78\u7a81\u7834\u514d\u4fb5\u5165\u5075\u6e2c\u5fc3\u81df\u3001\u809d\u81df\u9435\u8cea\u6c88\u7a4d\u91cf<\/a> (2020)<\/li>
                5. \u5e6b\u4e94\u6708\u5927\u5b30\u5152\u6d17\u6fa1\u6478\u5230\u816b\u584a \u7adf\u662f\u809d\u6bcd\u7d30\u80de\u764c<\/strong><\/a> (2016)<\/li>
                6. \u570b\u4e09\u5973\u6230\u52dd\u60e1\u6027\u6dcb\u5df4\u764c<\/strong> \u69ae\u7372\u7e3d\u7d71\u6559\u80b2\u734e<\/a> (2016)<\/li>
                7. \u6297\u8840\u764c<\/strong>\u5c0f\u9b25\u58eb\u8b8a\u767d\u8863\u5929\u4f7f \u5979\u7acb\u5fd7\u5b88\u8b77\u764c\u7ae5<\/a> (2015)<\/li>
                8. \u300c\u5149\u982d\u752d\u5439\u9aee\u300d\u7ae5\u6a02\u89c0\u6297\u764c<\/a> (2014)<\/li>
                9. \u8ce3\u9905\u7f55\u898b\u8840\u6db2\u75c5\u7ae5<\/strong>\u51fa\u9662 \u597d\u60f3\u4e0a\u5b78<\/a> (2014)<\/li>
                10. \u6350\u5e79\u7d30\u80de\u6551\u4eba\u3000\u65b0\u6350\u9ad3\u6280\u8853\u7121\u5f8c\u907a\u75c7<\/a> (2013)<\/li>
                11. \u5168\u7403\u9996\u4f8b \u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de<\/strong>-\u6551\u8840\u6db2\u75c5\u60a3 \u79fb\u690d7\u5929\u5c31\u80fd\u9020\u8840<\/a> (2011)<\/li>
                12. 921\u707d\u6c11\u6551\u8840\u764c<\/strong>\u5973 \u96e3\u625b\u91ab\u8cbb<\/a> (2010)<\/li>
                13. \u8a72\u70ba\u5bf6\u5bf6\u5b58\u81cd\u5e36\u8840<\/strong>\u55ce\uff1f<\/a> (2008)<\/li>
                14. \u4f86\u53f0\u63db\u9aa8\u9ad3<\/strong> \u8607\u4e39\u7537\u7ae5\u958b\u5fc3\u8fd4\u5bb6<\/a> (2008)<\/li>
                15. \u6148\u6bcd\u6350\u96a8<\/strong>\u6551\u91cd\u75c5\u611b\u5973 \u914d\u5c0d\u50c56\u6210\u543b\u5408 \u570b\u5167\u9996\u4f8b\u6210\u529f<\/a> (2005)<\/li>
                16. \u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de<\/strong> \u4eba\u9ad4\u8a66\u9a57\u6210\u529f<\/li>
                17. \u5168\u570b\u9996\u4f8b \u7f79\u60e1\u6027\u795e\u7d93\u6bcd\u7d30\u80de\u764c<\/strong>\u9760\u81cd\u5e36<\/strong>\u8840\u81ea\u6551<\/li>
                18. \u975e\u89aa\u5c6c\u81cd\u5e36\u8840\u79fb\u690d<\/strong> \u91cd\u5ea6\u6d77\u6d0b\u6027\u8ca7\u8840<\/strong>\u7ae5\u7372\u91cd\u751f (2007)<\/li>
                19. \u5168\u53f0\u9996\u4f8b \u81ea\u5b58\u81cd\u5e36\u8840<\/strong> \u7fa9\u6350\u6551\u547d (2007)<\/li>
                20. \u6297\u764c\u5c11\u5973 \u75c5\u53f2\u7de8\u6210\u821e (2007)<\/li>
                21. \u81cd\u5e36\u8840<\/strong>\u914d\u5c0d \u6a5f\u7387\u9ad8\u65bc\u9aa8\u9ad3 (2007)<\/li>
                22. \u91ab\u5e2b\uff1a\u81cd\u5e36\u8840<\/strong>\u91cf\u4e0d\u8db3 \u6cbb\u7642\u74f6\u9838\n(2007)<\/li>
                23. \u6bcd\u5403\u6ce1\u9eb5\u7701\u9322\u7c4c\u8840\u764c<\/strong>\u5152\u91ab\u8cbb (2007)<\/li><\/ol>\n\n\n\n

                  \u570b\u969b\u6703\u8b70\u9080\u8acb\u6f14\u8b1b<\/strong>(invited speaker)<\/strong><\/strong><\/p>\n\n\n\n

                  1. Thalassemia\nand Aplastic Anemia: From Past to Present (Cross-Strait Hematology Conference,\n2017)<\/li>
                  2. Clinical\napplication mesenchymal stem cells derived from umbilical cord in hematopoietic\nstem cell transplantation. (Perinatal Stem Cell Society Conference, USA, 2016)<\/li>
                  3. Clinical application of mesenchymal stem cells\nderived from umbilical cord in hematopoietic stem cell transplantion (AsiaCORD\nConference, Japan, 2013)<\/li>
                  4. Mesenchymal stem cells in\nhematopoietic stem cell transplantation (Japan-Korea-Taiwan Symposium on\nMaternal-Fetal Medicine, 2012)<\/li>
                  5. Comparisons of suppressive\neffects between human fetal-type mesenchymal stem cells (MSCs) and bone\nmarrow-derived MSCs (Cross-Strait Hematology Conference, 2011)<\/li>
                  6. Cotransplantation of\nhematopoietic stem cells and mesenchymal stem cells (Pan Pacific Symposium on\nStem Cells and Cancer Research, 2008)<\/li><\/ol>\n\n\n\n

                    \u7814\u7a76\u8a08\u5283<\/strong><\/strong><\/p>\n\n\n\n

                    (1).\u79d1\u6280\u90e8\u8a08\u5283\uff1a<\/strong>
                    \u4e3b\u6301\u4eba:
                    1. \u5f9e\u81cd\u5e36\u8840\u53ca\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u57f9\u990a\u5927\u91cf\u4eba\u985e\u8840\u7d05\u7d20(2007-2008)
                    2. \u4eba\u985e\u4e0d\u540c\u4f86\u6e90\u9593\u8cea\u5e79\u7d30\u80de\u5728\u79fb\u690d\u6297\u5bbf\u4e3b\u75be\u75c5\u7684\u6bd4\u8f03\u548c\u6a5f\u8f49\u7814\u7a76 (2011-2012)
                    3.\u5152\u7ae5\u91cd\u5ea6\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u75c5\u60a3\u9aa8\u9ad3\u9593\u8cea\u5e79\u7d30\u80de\u514d\u75ab\u8abf\u6574\u529f\u80fd\u548c\u57fa\u56e0\u8868\u73fe\u7684\u7814\u7a76(2013-1016)
                    4.\u80da\u80ce\u5230\u6210\u9ad4\u4e0d\u540c\u968e\u6bb5\u4e4b\u7d30\u80de\u4e0a\u6e05\u6db2\u514d\u75ab\u8abf\u6574\u529f\u80fd\u7684\u6bd4\u8f03\u8207\u6a5f\u8f49\u7814\u7a76(2017-2018)
                    5.\u7814\u7a76\u4eba\u985e\u5404\u7a2e\u80ce\u5152\u7d44\u7e54\u5916\u6ccc\u9ad4\u7684\u514d\u75ab\u8abf\u6574\u529f\u80fd\u53ca\u5176\u6a5f\u8f49(2018-2021)
                    \u5354\u540c\u4e3b\u6301\u4eba:
                    1. \u4e09\u968e\u6bb5\u652f\u6301\u6027\u8b77\u7406\u5c0d\u63a5\u53d7\u5e79\u7d30\u80de\u79fb\u690d\u75c5\u7ae5\u7167\u9867\u8005\u4e4b\u56f0\u64fe\u53ca\u751f\u6d3b\u54c1\u8cea\u6210\u6548\uff1a\u8de8\u6a5f\u69cb\u7e31\u8cab\u6027\u7814\u7a76(2016)
                    2. \u6bd4\u8f03\u4f86\u81ea\u4e0d\u540c\u80ce\u5152\u7d44\u7e54\u4e4b\u57f9\u990a\u6e05\u6db2\u8207\u9593\u8cea\u5e79\u7d30\u80de\u5c0d\u65bc\u6557\u8840\u75c7\u52d5\u7269\u7684\u514d\u75ab\u8abf\u7bc0\u6f5b\u529b\u8207\u6a5f\u8f49 (2016-2017)
                    3. \u5206\u6790\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u4e4b\u9aa8\u9ad3\u9593\u8cea\u5e79\u7d30\u80de\u53ca\u5176\u57f9\u990a\u6e05\u6db2 (2018-2019)
                    4. \u8a55\u4f30\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u4e4b\u9593\u8cea\u5e79\u7d30\u80de\u7684\u6539\u8b8a\u53ca\u9ec3\u8006\u5c0d\u5e79\u7d30\u80de\u7684\u5f71\u97ff (2019-2021)<\/p>\n\n\n\n

                    (2).\u570b\u885b\u9662\u8a08\u5283\u4e3b\u6301\u4eba<\/strong>
                    104\u5e74\u5152\u79d1\u91cd\u96e3\u75c7\u91ab\u7642\u7167\u8b77\u5718\u968a\u734e\u52f5\u65b9\u6848\u8a08\u756b(\u5152\u7ae5\u764c\u75c7)
                    105\u5e74\u5152\u79d1\u91cd\u96e3\u75c7\u91ab\u7642\u7167\u8b77\u5718\u968a\u734e\u52f5\u65b9\u6848\u8a08\u756b(\u5152\u7ae5\u764c\u75c7)<\/p>\n\n\n\n

                    (3).\u885b\u751f\u798f\u5229\u90e8<\/strong>
                    \u6574\u5408\u53f0\u7063\u5152\u7ae5\u764c\u75c7\u81e8\u5e8a\u6cbb\u7642\u53ca\u5206\u5b50\u8a3a\u65b7: \u5152\u7ae5\u6025\u6027\u767d\u8840\u75c5\u4e4b\u91ab\u7642\u7d93\u6fdf\u5b78\u5206\u6790(2018-2022)<\/p>\n\n\n\n

                    (4).\u7523\u5b78\u5408\u4f5c\u8a08\u5283\u4e3b\u6301\u4eba<\/strong>
                    1. \u8a0a\u806f\u751f\u7269\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u81cd\u5e36\u8840\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u79fb\u690d(2007-2009) (\u7372\u7d93\u6fdf\u90e8\u5de5\u696d\u5c40\u5343\u842c\u7d93\u8cbb\u88dc\u52a9)
                    2. \u5927\u5c55\u751f\u547d\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u7f3a\u8840\u53ca\u7f3a\u6c27\u6027\u9ad8\u5371\u96aa\u598a\u4e4b\u5a20\u81cd\u5e36\u8840\u4e3b\u52d5\u7559\u5b58\u76f8\u95dc\u91ab\u7642\u8f14\u52a9\u7814\u7a76 (2009\/01\/01-2009-12\/31)
                    3. \u8f1d\u745e\u5927\u85e5\u5ee0\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u4e00\u500b\u524d\u77bb\u6027\u3001\u958b\u653e\u6027\u6a19\u793a\u4e4b\u7814\u7a76\uff1a\u8a55\u4f30anidulafungin\u65bc \u6cbb\u7642\u4fb5\u5165\u6027\u5ff5\u73e0\u83cc\u611f\u67d3(\u5305\u62ec\u5ff5\u73e0\u83cc\u8840\u75c7)\u4e4b\u5152\u7ae5\u4e4b\u85e5\u7269\u52d5\u529b\u5b78\u3001\u5b89\u5168\u6027\u53ca\u7642\u6548 (2011-2013)
                    4. \u751f\u5bf6\u751f\u7269\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u7684\u5be6\u9a57\u548c\u6a5f\u8f49\u5206\u6790 (2012-2013)
                    5. \u53f0\u7063\u5c16\u7aef\u5148\u9032\u751f\u6280\u91ab\u85e5\u80a1\u4efd\u6709\u9650\u516c\u53f8: TAT-HOXB4\u86cb\u767d\u5c0d\u81cd\u5e36\u8840\u589e\u751f\u5f8c\u79fb\u690d\u6548\u679c (2013-2016)<\/p>\n\n\n\n

                    (5).\u91ab\u5b78\u4e2d\u5fc3\u7814\u7a76\u8a08\u5283<\/strong>
                    \u4e3b\u6301\u4eba:
                    1. \u798f\u5584\u7f8e\u9320(fosamaxtablets)\u5728\u4e59\u578b\u91cd\u5ea6\u6d77\u6d0b\u6027\u8ca7\u8840\u75c5\u60a3\u9aa8\u8cea\u758f\u9b06\u7684\u6cbb\u7642(2005)
                    2. \u7531\u9031\u908a\u9020\u8840\u5e79\u7d30\u80de\u5728\u9ad4\u5916\u57f9\u990a\u6210\u4eba\u985e\u7d05\u8840\u7403(2007)
                    3. \u5f9e\u4eba\u985e\u80da\u80ce\u5e79\u7d30\u80de\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u57f9\u990a\u4eba\u985e\u9020\u8840\u5e79\u7d30\u80de(2007)
                    4. \u9aa8\u9ad3\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5728\u4e0d\u540c\u4ee3\u6578\u5c0dT\u6dcb\u5df4\u7d30\u80de\u6291\u5236\u4f5c\u7528\u7684\u6bd4\u8f03(2009)
                    5. \u4eba\u985e\u4e0d\u540c\u4f86\u6e90\u9593\u8cea\u5e79\u7d30\u80de\u5728\u79fb\u690d\u6297\u5bbf\u4e3b\u75be\u75c5\u548c\u514d\u75ab\u8abf\u6574\u529f\u80fd\u5728\u9ad4\u5167\u7684\u6bd4\u8f03\u53ca\u6a5f\u8f49\u7814\u7a76(2010)
                    6. \u96a8\u6a5f-\u96d9\u76f2\u8a66\u9a57-\u8a55\u4f30\u975c\u8108\u5de6\u65cb\u9ea9\u91af\u80fa\u9178\uff08L-Glutamine\uff09\u5c0d\u8a3a\u65b7\u70ba\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09\u4e4b\u5152\u7ae5\u75c5\u60a3\u63a5\u53d7\u5316\u7642\u85e5\u7269\uff08MTX\uff09\u5f8c\u5f15\u8d77\u4e4b\u53e3\u8154\u9ecf\u819c\u708e\u3001\u71df\u990a\u53ca\u751f\u6d3b\u54c1\u8cea\u7684\u6539\u5584\u60c5\u5f62(2011)
                    7. \u4ee5\u4eba\u985e\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u4e0a\u6e05\u6db2\u6cbb\u7642\u6557\u8840\u75c7\u8001\u9f20(2013)
                    8. \u4ee5\u6642\u9593\u5e8f\u5217\u63a2\u8a0e\u548c\u6bd4\u8f03Toll-like\u53d7\u9ad4\u5728\u9aa8\u9ad3\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u6642\u7684\u6a5f\u8f49(2014)
                    9. \u9ec3\u8006\u5c0d\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u7684\u5f71\u97ff\u53ca\u5176\u6a5f\u8f49\u7684\u63a2\u8a0e(2015)
                    10.\u4ee5\u6642\u9593\u5e8f\u5217\u63a2\u8a0eToll-like\u53d7\u9ad4\u5728\u4eba\u985e\u7d68\u6bdb\u7d30\u80de\u4e0a\u6e05\u6db2\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u6642\u7684\u6a5f\u8f49(2017)
                    11. \u63a2\u8a0e\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u5e79\u7d30\u80de\u4e4b\u7f3a\u9677(2019)
                    <\/p>\n\n\n\n

                    \u570b\u969b<\/strong>SCI<\/strong>\u96dc\u8a8c\u767c\u8868<\/strong>(2002-2020\uff0c\u6309\u5e74\u4ee3\u9806\u5e8f):<\/p>\n\n\n\n

                    1. Wu KH<\/strong>,\nChang JG, Lin M, Shih MC, Lin HC, Lee CC, Peng CT, Tsai CH.<\/a> Hydrops foetalis caused by anti-mur in first\npregnancy–a case report. Transfus Med. 2002;12:325-7. <\/li>
                    2. Wu KH<\/strong>,\nChu SL, Chang JG, Shih MC, Peng CT. Haemolytic disease of the newborn due to\nmaternal irregular antibodies in Chinese population in Taiwan. Transfus Med.\n2003;13:311-4. <\/li>
                    3. Wu KH<\/strong>,\nTsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with b-thalassemia\nmajor and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82:637-40.\n<\/li>
                    4. Wu\nKH<\/strong>, <\/strong>Chang JS, Tsai CH, Peng CT. Combined\ntherapy with deferiprone and desferrioxamine successfully regresses severe\nheart failure in patients with beta-thalassemia major. Ann Hematol. 2004;83:471-3.\n(Times Cited: <\/strong>57<\/strong><\/a> from Web of Science in 2020)<\/strong><\/li>
                    5. Wu KH<\/strong>,\nChang JS, Su BH, Peng CT.<\/a> Tricuspid\nregurgitation in patients with beta-thalassemia major. Ann Hematol. 2004;\n83:779-83.  <\/li>
                    6. Shih\nMC, Wu KH<\/strong>, Liu SC, Chang JG.<\/a> Hb Tak: a beta chain elongation at the end of the beta\nchain, in a Taiwanese. Hemoglobin. 2005; 29:65-7.  <\/li>
                    7. Wu\nKH, <\/strong>Peng CT, Li TC, Wan L, Tsai CH, Lan SJ, Chang\nMC, Tsai FJ . Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in\nchildren with acute and chronic immune thrombocytopenic purpura. Br J Haematol<\/strong>. 2005; 128:849-52.  <\/li>
                    8. Peng\nCT, Wu KH<\/strong>, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH.<\/a> Amino acid concentrations in cerebrospinal fluid in\nchildren with acute lymphoblastic leukemia undergoing chemotherapy. Eur J\nCancer. 2005; 41:1158-63. <\/li>
                    9. Peng\nCT, Wu KH*<\/strong>, Wu SF, Liang DC, Yang CP, Jang RC, Wang LY, Hsiao CC.<\/a> Deferiprone or deferoxamine vs. combination therapy in\npatients with beta-thalassemia major: a case study in Taiwan. Hemoglobin. 2006;30:125-30.\n(*corresponding author)<\/li>
                    10. Kuo HT, Tsai MY, Peng CT, Wu KH<\/strong>.\nPilot Study on \u201cQuality of Life\u201d as reflected by psychosocial adjustment of\nchildren with thalassemia major undergoing iron-chelating treatment in west\nTaiwan. Hemoglobin.2006;30:291-9. <\/li>
                    11. Wang CH, Wu KH<\/strong>, Tsai FJ, Peng CT.\nComparison of oral and subcutaneous iron chelation therapy in prevention of\nmajor endocrinopathies in b-thalassemia\nmajor patients. Hemoglobin.2006;30:257-62. <\/li>
                    12. Wu\nKH<\/strong>, <\/strong>Chang JG, Ho YJ, Wu SF, Peng CT. <\/sup>Glutathione\nS-transferase M1 gene polymorphisms are associated with cardiac iron deposition\nin patients with b-thalassemia\nmajor.Hemoglobin.2006;30:251-6. <\/li>
                    13. Huang\nYC, Chang JS, Wu KH<\/strong>, Peng CT. Regression of myocardial dysfunction\nafter switching from deferoxamine to deferiprone in b-thalassemia major patients. Hemoglobin. 2006;\n30:229-38. <\/li>
                    14. Wu SF, Peng CT, Wu KH<\/strong>, Tsai CH.Liver\nfibrosis and iron levels during long-term treatment of thalassemia major\npatients with deferiprone. Hemoglobin. 2006; 30:215-8. <\/li>
                    15. Chen AC, Peng CT, Wu SF, Wu KH<\/strong>, Chiang\nIP, C-H Tsai CH.Effect of deferiprone on liver iron overload and fibrosis in\nhepatitis C virus infected thalassemia. Hemoglobin. 2006; 30:209-14. <\/li>
                    16. Wei CC,\nPeng CT, Chiang IP, Wu KH*<\/strong>.\nPrimary B cell non-Hodgkin\u2019s lymphoma of the penis in a child. J Pediatr\nHematol Oncol. 2006; 28:479-80. (*corresponding\nauthor) <\/li>
                    17. Wu KH<\/strong>,\nPeng CT, Li TC, Wan L, Tsai CH, Tsai FJ. Interleukin 1\u03b2 Exon 5 and interleukin\n1 receptor antagonist in children with acute and chronic immune\nthrombocytopenic purpura. J Pediatr Hematol Oncol. 2007; 29:305-8. <\/li>
                    18. Peng CT<\/a>, Tsai CH<\/a>, Wu\nKH<\/strong>. Effects of chelation therapy on cardiac function improvement in\nthalassemia patients: literature review and the Taiwanese experience. Hemoglobin.<\/a>\n2008;32:49-62. <\/li>
                    19. Wu\nSF, Chen AC, Peng CT, Wu KH*<\/strong>. Octreotide therapy in asparaginase-associated\npancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer.<\/a>\n2008;51:824-5. (*corresponding author)<\/li>
                    20. Peng\nCT, Chang JS, Wu KH, <\/strong>Tsai CH, Lin SH. Mechanisms of and obstacles\nto iron cardiomyopathy in thalassemia. Front\nBiosci.<\/a> 2008; 13:5975-87. <\/li>
                    21. Lin CH<\/a>, Wu\nKH<\/strong>, Lin WC<\/a>, Tsai JD<\/a>, Peng CT<\/a>, Chen AC<\/a>. Granulocytic sarcoma of the colon in a child with acute myeloid\nleukemia presenting as hematochezia. J Pediatr Hematol Oncol.<\/a> 2008; 30:981-3. <\/li>
                    22. Chang\nYH<\/a>, Shaw\nCF<\/a>, Wu KH<\/strong><\/a>, Hsieh\nKH<\/a>, Su\nYN<\/a>, Lu\nPJ<\/a>. Treatment with deferiprone for iron overload\nalleviates bone marrow failure in a Fanconi anemia patient. Hemoglobin.<\/a> 2009; 33: 346-51. <\/li>
                    23. Peng CT<\/a>, Chang JS<\/a>, Wang LY<\/a>, Chiou SS<\/a>, Hsiao CC<\/a>, Wang SC<\/a>, Hung GY<\/a>, Wu KH<\/a>*<\/strong>.\nUpdate on thalassemia treatment in Taiwan, including bone marrow\ntransplantation, chelation therapy, and cardiomyopathy treatment effects. Hemoglobin.<\/a> 2009; 33:304-11. (*corresponding author)<\/li>
                    24. Wu KH<\/strong>,\nWang CH, Yang YL, Peng, CT, Lin WD, Tsai FJ, Lin DT, Bau DT. Significant\nassociation of XRCC4 single nucleotide polymorphisms with child leukemia in\nTaiwan. Anticancer\nRes.<\/a> 2010;\n30:529-34. <\/li>
                    25. Liang DC, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS,\nHsiao CC, Chang TT, Peng CT, Lin MT, Chang TK, Jaing TH, Liu HC, Wang LY, Yeh\nTC, Jou ST, Lu MY, Cheng CN, Sheen JM, Chiou SS, Wu KH<\/strong>, Hung GY, Chen RL, Chen SH, Cheng SN, Chang YH, Chen\nBW, Ho WL, Wang JL, Lin ST, Hsieh YL, Wang SC, Chang HH, Yang YL, Huang FL,\nChang CY, Chang WH, Lin KS. Long-term results of Taiwan pediatric oncology group studies 1997\nand 2002 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:397-405. <\/li>
                    26. Lin\nCH, Lin WC, Chiang IP, Ho YJ, Peng CT, Wu KH<\/a>*<\/strong>.\nLangerhans cell histiocytosis with thyroid and lung involvement in a child: a\ncase report. J Pediatr Hematol Oncol. 2010;32:309-11. (*corresponding author)<\/li>
                    27. Lin CH, Lin WC, Wang CH, Ho YJ, Chiang IP <\/sup>, Peng CT, Wu KH<\/a>*<\/strong>. Child with ataxia telangiectasia developing acute\nmyeloid leukemia. J Clin Oncol<\/strong>.<\/strong> 2010; 28:213-4. (SCI: 32.956 in 2020)<\/strong> (*corresponding author)<\/li>
                    28. Lee\nWI, Huang JL, Jaing TH, Wu\nKH<\/strong>, Chien YH, Chang KW. Clinical aspects and genetic analysis\nof Taiwanese patients with Wiskott-Aldrich syndrome protein mutation: the first\nidentification of x-linked thrombocytopenia in the Chinese with novel\nmutations. J Clin\nImmunol.<\/a> 2010; 30:593-601. <\/li>
                    29. Chao\nYH, Peng CT, Harn HJ, Chan CK, Wu KH<\/a>*<\/strong>. Poor potential of proliferation and\ndifferentiation in bone marrow mesenchymal stem cells derived from children\nwith severe aplastic anemia. Ann Hematol. 2010; 89:715-23. (*corresponding author)<\/li>
                    30. Wang\nCH, Wu KH<\/a>*<\/strong>,\nYang YL, Peng CT, Wang RF, Tsai CW, Tsai RY, Lin DT, Tsai FJ, Bau DT.\nAssociation study of cyclooxygenase 2 single nucleotide polymorphisms and\nchildhood acute lymphoblastic leukemia in Taiwan. Anticancer Res. 2010;\n30:3649-3653. (*equal contribution author)<\/li>
                    31. Yang YL, Lin SR, Chen JS, Hsiao CC, Lin KH, Sheen JM, Cheng CN, Wu KH<\/strong>, Lin SW, Yu SL, Chen HY,\nLu MY, Chang HH, Yen CT, Lin JF, Su YH, Li YP, Lin CY, Jou ST, Lin DT.\nMultiplex reverse transcription-polymerase chain reaction as diagnostic\nmolecular screening of 4 common fusion chimeric genes in Taiwanese children\nwith acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010; 32:323-30.   <\/li>
                    32. Chao YH, Tsai C, Peng CT, Wu HP, Chan CK, Weng TF, Wu KH<\/a>*<\/strong>. Cotransplantation of umbilical cord mesenchymal stem\ncells to enhance engraftment of hematopoietic stem cells in patients with\nsevere aplastic anemia. Bone Marrow Transplant. 2010; 46:1391-2 (*corresponding author)<\/li>
                    33. Su BH, Wu KH\uff03<\/sup>, Lin HY, Lin MH, Peng CT, Tsai C. Umbilical cord-derived\nmesenchymal stem cells for severe bronchpulmonary dysplasia. Pediatrics. 2011;\n26:1127-33. (\uff03<\/sup>equally author)<\/li>
                    34. Wu KH, Chan CK, Tsai C, Chang YH, Sieber Martin, Chiu TH, Ho M,\nPeng CT, Wu HP, Huang JL. Effective\ntreatment of severe steroid-resistant acute graft-versus-host disease with\numbilical cord-derived mesenchymal stem cells. Transplantation. 2011; 91:1412-6.\n(Times Cited: <\/strong>78<\/strong><\/a> from Web of Science in 2020 )<\/strong><\/li>
                    35. Yang WC, Chen JY, Wu KH<\/strong>,\nWu HP. Acute onset of dizziness caused by a cavernous malformation lateral\nto the fourth ventricle: a case report. Pediatr Neonatol. 2011; 52:113-6. <\/li>
                    36. Chao\nYH, Wu HP, Chiang IP, Peng CT, Yang YL, Wu KH<\/a>*<\/strong>. Rhabdomyomatous\ndifferentiation in primary Wilms tumor and hepatic metastases after\nchemotherapy and all-trans-retinoic acid in combination with interferon-\u03b1. Pediatr\nBlood Cancer. 2011; 57:698-9. (*corresponding author)<\/li>
                    37. Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC,\nSheen JM, Cheng CN, Wu KH<\/strong>,\nLin SR, Yu SL, Chen HY, Lu MY, Wang SC, Chang HH, Lin SW, Su YN, Lin DT. IKZF1\ndeletions predict a poor prognosis in children with B-cell progenitor acute\nlymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci. 2011; 102:1874-81. <\/li>
                    38. Lee\nWI*, Huang JL*, Jaing TH, Shyur SD, Yang KD, Chien YH, Chiang BL, Soong WJ,\nChiou SS, Shieh CC, Lin SJ, Yeh KW, Chen LC, Ou LS, Yao TC, Lin TY, Chiu CH,\nHuang YC, Wu KH<\/strong>, Lin CY, Yu\nHH, Yang YH, Yu HR, Yen HJ, Hsieh MY, Kuo ML, Hwu WL, Tsai YC, Kuo HC, Lin YL,\nShih YF, Chang KW. Distribution,\nclinical features and treatment in Taiwanese patients with symptomatic primary\nimmunodeficiency diseases (PIDs) in a nationwide population-based study during\n1985-2010. Immunobiology. 2011; 216:1286-94. (*corresponding author)<\/li>
                    39. Li YC<\/a>, Chen CY<\/a>, Huang MY<\/a>, Wu KH<\/strong>, Yang WC<\/a>, Wu HP<\/a>. Significant\nchange between primary and repeated serum laboratory tests at different time\npoints in pediatric appendicitis. Eur J Emerg Med.<\/a>\n2011; 19:395-9. <\/li>
                    40. Yin-Yi Chang C, Wu KH,<\/strong> Lin TY,\nChang WC, Lin WC, Hung YC, Yeh LS. Vulvar yolk sac tumor mixed with\nembryonal carcinoma in a peri-pubertal girl: A case report.<\/a> Taiwan J Obstet Gynecol. 2011; 50:503-5. <\/li>
                    41. Wang CH,\nWu KH<\/strong>, Yang YL, Peng CT, Tsai FJ, Lin DT, Chiu CF, Lin CC, Bau DT.\nAssociation between ataxia telangiectasia mutated gene polymorphisms and childhood\nleukemia in Taiwan. Chin J Physiol. 2011; 54:413-8. <\/li>
                    42. Chan CK, Wu KH<\/strong>\uff03<\/sup><\/strong>, Lee SH, Hwang SM, Lee MS,\nLiao SK, Cheng EH, See LC, Tsai CN, Kuo ML, Huang JL. The comparison of interleukin-6 associated immunosuppressive\neffects of human ESCs, fetal-type MSCs, and adult-Type MSCs. Transplantion. 2012;94:132-8 (\uff03<\/sup>equally author)<\/li>
                    43. Weng\nTF, Ho MW, Lin HC, Lu MY, Peng CT, Wu KH<\/a>*<\/strong>. Successful\ntreatment of disseminated mixed invasive fungal infection after hematopoietic\nstem cell transplantation for severe aplastic anemia. Pediatr Transplant. 2012;16:35-8. (*corresponding author)<\/li>
                    44. Wu HP<\/a>, Yang WC<\/a>,Wu KH<\/strong><\/a>, Chen CY<\/a>, Fu YC<\/a>. Diagnosing appendicitis at different time points\nin children with right lower quadrant pain: comparison between pediatric appendicitis\nscore and the alvarado score. World J\nSurg.<\/a> 2012; 36:216-21. <\/li>
                    45. Chen CY<\/a>, Yang WC<\/a>, Wu KH<\/strong><\/a>, Wu HP<\/a>. Clinical\njudgment of children with first-attack seizures admitted to the ED. Am J Emerg Med.<\/a> 2012\nSep;30(7):1080-8. <\/li>
                    46. Yang\nYL, Hsiao CC, Chen HY, Lin KH, Jou ST, Chen JS, Chang TK, Sheen JM, Yu SL, Lu\nMY, Cheng CN, Wu KH<\/strong>, Wang SC,\nWang JD, Chang HH, Lin SR, Lin SW, Lin DT. Absence of biallelic TCR\u03b3 deletion predicts\nintroduction failure and poorer outcomes in childhood T-cell acute lymphoblastic\nleukemia. Pediatr Blood Cancer. 2012;58:846-51.<\/li>
                    47. Chao\nYH, Wu HP, Chan CK, Tsai C, Peng CT, Wu\nKH*<\/strong>. Umbilical Cord-Derived Mesenchymal Stem Cells for Hematopoietic\nStemCell Transplantation. J Biomed Biotechnol.<\/a> 2012;\n2012:759503.\n(*corresponding author)<\/li>
                    48. Chao\nYH, Wu KH<\/strong>, Lu JJ, Shih MC, Peng CT, Chang CW. RBC\nalloimmunization among Chinese patients with \u03b2-thalassemia major in Taiwan.\nBlood Transfus. 2013;11:71-74.<\/li>
                    49. Wu KH<\/strong>,\nTasi C, Wu HP, Sieber M, Chao YH, Peng CT. Human Application of Ex-Vivo\nExpanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesis\nafter Cord Blood Transplantation. Cell Transplant. 2013;22:2041-51.<\/li>
                    50. Liu CH, Wu KH<\/strong>,\nLin TY, Wei CC, Lin CY, Chen XX, Lee WI.\nWiskott-Aldrich syndrome with IgA nephropathy: a case report and\nliterature review. Int Urol Nephrol. 2013; 45:1495-500.<\/li>
                    51. Wu KH<\/strong>,\nWang SM, Wu HP, Weng T, Peng CT, Chao YH. Autologous cord blood transplantation\nin a child with stage 4 neuroblastoma. Bone Marrow Transplant. 2013;48:317-8. <\/li>
                    52. Lin WC, Lin CH, Wu HP, Lin HC, Wu KH*<\/strong>. Simultaneous Pulmonary and Inferior Vena Cava Thromboembolism\nSecondary to Pelvic Osteosarcoma. J Pediatr Hematol Oncol.\n2013;35:e320-2 (*corresponding\nauthor) <\/li>
                    53. Tamamyan G, Chao YH, Wang CH, Wu HP, Weng T, Peng\nCT, Wu KH<\/strong>*. Dasatinib Plus\nChemotherapy to Achieve Full Donor Chimerism and Complete Molecular Remission in\na Child with Relapsed Philadelphia Chromosome-positive Acute Lymphoblastic\nLeukemia. Pediatr Blood Cancer. 2013;60:1727-1728 (*corresponding author)<\/li>
                    54. Chen CY, Zhao LL, Lin YR, Wu KH<\/strong>, Wu HP*<\/sup>. Different urinalysis appearances\nin children with simple and perforated appendicitis. Am J Emerg Med. 2013; 31:1560-1563.<\/li>
                    55. Chao YH, Sheu JN, Chen SM, Wu KH<\/strong>*. Diagnostic Paracentesis\nin an Acute Lymphoblastic Leukemia Child without Characteristic Symptoms of\nPancreatitis. Journal\nof Pediatric Hematology\/Oncology. 2013; 35:e47-e47. (*corresponding author)<\/li>
                    56. WC Yang, YR Lin, LL Zhao, YK Wu, YJ Chang, CY\nChen, KH Wu<\/strong>, HP Wu*. Epidemiology\nof Pediatric Critically-ill Patients Presenting to the Pediatric Emergency Department.\nKlinische Pediatrie. 2013;225:18-23. <\/li>
                    57. Sheu JN, Wu\nKH<\/strong>, Chen SM, Tsai JD, Chao YH, Lue KH*. Acute 99mTc DMSA Scan Predicts\nDilating Vesicoureteral Reflux in Young Children With a First Febrile Urinary\nTract Infection: A Population-Based Cohort Study. Clinical Nuclear Medicine. 2013;\n38:163-168. <\/li>
                    58. Wu KH<\/strong>, Sheu JN, Wu HP, Tsai C, Sieber M, Peng CT, Chao YH*. Cotransplantation\nof Umbilical Cord-Derived Mesenchymal Stem Cells Promote Hematopoietic\nEngraftment in Cord Blood Transplantation: A Pilot Study. Transplantation. 2013;\n95:773-7. <\/li>
                    59. Wang CH, Lai YL, Chang WS, Wu KH<\/strong>, Lane HY, Chiu CF, Tsai\nFJ, Lin CC, Bau DT. Significant Association of Caveolin-1 Single Nucleotide\nPolymorphisms with Childhood Leukemia in Taiwan. Cancer Genomics Proteomics. 2013;10:75-79. <\/li>
                    60. Wu KH<\/strong>, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH.The Role of\nMesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation: from Bench\nto Bedsides. Cell Transplant. 2013;22:723-729.  <\/li>
                    61. Chen CY, Lin YR, Zhao LL, Wu YK, Chang YJ,\nYang WC, Wu KH<\/strong>, Wu HP. Epidemiology\nand outcome analysis of children with traumatic out-of-hospital cardiac arrest\ncompared to nontraumatic cardiac arrest. Pediatr Surg Int. 2013; 29:471-477. <\/li>
                    62. Sun HL,\nWu KH<\/strong>, Chen SM, Chao YH, Ku MS, Hung TW, Liao PF, Lue KH, Sheu JN. Role\nof Procalcitonin in Predicting Dilating Vesicoureteral Reflux in Young Children\nHospitalized. Pediatr Infect Dis J. 2013; 32:e348-e354. <\/li>
                    63. Chen CY, Lin YR, Zhao LL, Yang WC, Chang YJ, Wu KH<\/strong>, Wu HP. Clinical spectrum\nof rhabdomyolysis presented to pediatric emergency department. BMC Pediatrics. 2013;\n13:1-6. <\/li>
                    64. Lin WC, Lin CH, Chao YH, Lin HC, Chen PY, Wu\nHP, Wu KH<\/strong>*<\/sup>. Simultaneous\nPulmonary and Inferior Vena Cava Thromboembolism Secondary to Pelvic\nOsteosarcoma. J Pediatr Hematol Oncol. 2013; 35:e320-e322. (*corresponding author)<\/li>
                    65. Chao YH, Wu\nKH<\/strong>, Lin CY, Tsai MH, Peng CT, Wu HP, Lin CD. Audiologic and Vestibular\nAssessment in Patients With \u03b2-Thalassemia Major Receiving Long-Term Transfusion Therapy. Pediatr\nBlood Cancer. 2013;60:1963-6.  <\/li>
                    66. Wu KH<\/strong>, Chan CK, Chao YH, Peng CT, Huang JL. Clinical Consideration\nfor Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation. Transplantation.\n2013; 96:e86-e87.  <\/li>
                    67. Lin CY, Li MJ, Chang JG, Liu SC, Weng T, Wu KH<\/strong>, Yang SF, Huang FK, Lo WY,\nPeng CT. High-resolution melting analyses for genetic variants in ARID5B and\nIKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in\nTaiwan. Blood Cells Mol Dis. 2014; 2014:140-145. <\/li>
                    68. Chao YH, Wu HP, Wu KH<\/strong>#<\/sup>, Tsai YG, Peng CT, Lin KC, Chao WR, Lee\nMS, Fu YC. An increase in CD3+CD4+CD25+ regulatory T cells after administration\nof umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One. 2014;\n9:e110338 (#equal contribution) <\/li>
                    69. Wu KH,<\/strong> Weng T, Wu HP, Peng CT, Sheu JN, Chao YH. Effective\ntreatment of severe BK virus-associated hemorrhagic cystitis with leflunomide\nin children after hematopoietic stem cell transplantation: a pilot study.\nPediatr Infect Dis J. 2014; 33:1193-5. <\/li>
                    70. Chao YH, Wu\nKH<\/strong>#<\/sup>, Wu HP, Liu SC, Peng CT, Lee MS. Clinical features and\nmolecular analysis of Hb H disease in Taiwan. Biomed Res Int. 2014:271070. (#equal\ncontribution) <\/li>
                    71. Cho FN, Chang TH, Shu CW, Ko MC, Liao SK, Wu KH<\/strong>, Yu MS, Lin SJ, Hong YC,\nChen CH, Hung CH, Chang YH. Enhanced cytotoxicity of natural killer cells\nfollowing the acquisition of chimeric antigen receptors through trogocytosis.\nPLoS One. 2014;9:e109352. <\/li>
                    72. Chao YH, Wu KH#<\/sup>, Chiou SH, Chiang\nSF, Huang CY, Yang HC, Chan CK, Peng CT, Wu HP, Chow KC, Lee MS. Downregulated\nCXCL12 expression in mesenchymal stem cells associated with severe aplastic\nanemia in children. Ann Hematol. 2015;94:13-22. (#<\/sup>equal contribution)\n<\/li>
                    73. Wu KH<\/strong>, Wu HP, Weng T, Peng CT, Chao YH. Dasatinib for a child\nwith Philadelphia chromosome-positive acute lymphoblastic leukemia and\npersistently elevated minimal residual disease during imatinib therapy. Curr\nOncol. 2015; 22:303-306. <\/li>
                    74. Li\nYC, Chen CY, Wu KH<\/strong>, Kuo HT,\nWu HP. Recurrent Streptococcus Pneumoniae 23 F\nmeningitis due to cerebrospinal fluid leakage from\nthe ear cannel: a case report. BMC Pediatr. 2015;15:195. <\/li>
                    75. Lin CH, Lin WC, Lai IH, Wu SF, Wu KH<\/strong>, Chen AC. Pediatric gastric cancer presenting with\nmassive ascites. World J Gastroenterol. 2015;21:3409-13.<\/li>
                    76. Wu KH<\/strong>, Chao WR, Lo WY, Tseng PC, Lee CJ, Peng CT, Lee MS, Wu\nHP, Chao YH. Time-Series Expression of Toll-Like Receptor 4 Signaling in Septic\nMice Treated With Mesenchymal Stem Cells. Shock. 2016;45:634-40. <\/li>
                    77. Yen\nHJ, Chang WH, Liu HC, Yeh TC, Hung GY, Wu\nKH<\/strong>, Peng CT, Chang YH, Chang TK, Hsiao CC, Sheen JM, Chao YH, Chang TT,\nChiou SS, Lin PC, Wang SC, Lin MT, Ho WL, Chen YC, Liang DC. Outcomes Following\nDiscontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in\nChildren With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer.\n2016;63:665-70. <\/li>
                    78. Weng TF, Wu KH<\/strong>#<\/sup>, Wu HP, Peng CT, Chao YH. Changes of serum aspergillus\ngalactomannan during hematopoietic stem cell transplantation in children with\nprior invasive aspergillosis. Ital J Pediatr. 2016;42:30. (#equal contribution)<\/li>
                    79. Chen CY, Kuo HT, Chang YJ, Wu KH<\/strong>, Yang WC, Wu HP. Clinical assessment of children with\nrenal abscesses presenting to the pediatric emergency department. BMC Pediatr.\n2016;16:189.<\/li>
                    80. Wu KH<\/strong>, Wu HP, Lin HJ, Wang CH, Chen HY, Weng T, Peng CT, Chao\nYH. Concurrent hypopituitarism and leukemic retinopathy in a child with\nB-precursor acute lymphoblastic leukemia and isolated central nervous system\nrelapse. Curr Oncol. 2016;23:e431-4.<\/li>
                    81. Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, Chang\nKM, Lu MY, Hwang WL, Koh LP, Chen TY, Leung AY, Norasetthada L, Wang SC, Chang\nMC, Wu KH<\/strong>, Issaragrisil S. Efficacy\nof rabbit antithymocyte globulin as first-line treatment of severe aplastic\nanemia: an Asian multicenter retrospective study. Int J Hematol.\n2016;104:454-61.<\/li>
                    82. Lin HC, Chao YH, Wu\nKH<\/strong>, Yen TY, Hsu YL, Hsieh TH, Wei HM, Wu JL, Muo CH, Hwang KP, Peng CT,\nLin CC, Li TC. Increased risk of herpes zoster in children with cancer: A\nnationwide population-based cohort study. Medicine (Baltimore). 2016; 95:e4037.<\/li>
                    83. Chan CK, Lin TC, Huang YA, Chen YS, Wu CL, Lo HY, Kuo ML,\nWu KH*<\/sup><\/strong>, Huang JL. The\nmodulation of Th2 immune pathway in the immunosuppressive effect of human\numbilical cord mesenchymal stem cells in a murine asthmatic model. Inflamm Res.\n2016;65:795-801.\n(*corresponding author)<\/li>
                    84. Yang CA, Lin JA, Chang CW, Wu KH<\/strong>, Yeh SP, Ho CM, Chang JG. Selection of GP. Mur\nantigen-negative RBC for blood recipients with anti-‘Mia ‘ records decreases\ntransfusion reaction rates in Taiwan. Transfus Med. 2016;26:349-354.<\/li>
                    85. Huang MY, Chen CY, Chien JH, Wu KH, Chang Y, Wu KH<\/strong>, Wu HP. Serum\nProcalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients\nwith Severe Sepsis and Septic Shock. Biomed Res Int. 2016;2016:1758501.<\/li>
                    86. Lin CH, Chao YH, Wu\nKH<\/strong>, Lin WC. Primary mucoepidermoid carcinoma at the carina of trachea\npresenting with wheezing in an asthmatic child mimicking an attack of asthma: A\ncase report. Medicine (Baltimore). 2016;95:e5292.<\/li>
                    87. Yang WC, Kuo HT, Lin CH, Wu KH<\/strong>, Chang YJ, Chen CY, Wu HP. Tympanic temperature versus\ntemporal temperature in patients with pyrexia and chills. Medicine (Baltimore).\n2016;95:e5267.<\/li>
                    88. Wu HP, Lin CL, Chang YC, Wu KH<\/strong>, Lei RL, Peng CT, Weng T, Tai YM, Chao YH. Survival\nand complication rates in patients with thalassemia major in Taiwan. Pediatr\nBlood Cancer. 2017;64:135-8. <\/li>
                    89. Li MJ, Liu HC, Yen HJ, Jaing TH, Lin DT, Yang CP, Lin KH,\nHung IJ, Jou ST, Lu MY, Hsiao CC, Peng CT, Chang TT, Wang SC, Lin MT, Chen JS,\nChang TK, Hung GY, Wu KH<\/strong>,\nYang YL, Chang HH, Chen SH, Yeh TC, Cheng CN, Lin PC, Chiou SS, Sheen JM, Cheng\nSN, Chen SH, Chang YH, Ho WL, Chao YH, Chen RL, Chen BW, Wang JL, Hsieh YL,\nLiao YM, Yang SH, Chang WH, Chao YY, Liang DC. Treatment for childhood acute\nlymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002\nstudy emphasizing optimal reinduction therapy and central nervous system\npreventive therapy without cranial radiation. Pediatr Blood Cancer.\n2017;64:234-241.<\/li>
                    90. Sun KT, Huang YN, Palanisamy K, Chang SS, Wang IK, Wu KH<\/strong>, Chen P, Peng CT, Li CY. Reciprocal\nregulation of \u03b3-globin expression by exo-miRNAs: Relevance to \u03b3-globin\nsilencing in \u03b2-thalassemia major. Sci Rep. 2017;7:202.<\/li>
                    91. Wu HP, Lin MJ, Yang WC, Wu KH<\/strong>, Chen CY. Predictors of Extracorporeal Membrane\nOxygenation Support for Children with Acute Myocarditis. Biomed Res Int. 2017:2510695.<\/li>
                    92. Chang YH, Yu MS, Wu\nKH<\/strong>, Hsu MC, Chiou YH, Wu HP, Peng CT, Chao YH. Effectiveness of Parenteral\nGlutamine on Methotrexate-induced Oral Mucositis in Children with Acute\nLymphoblastic Leukemia. Nutr Cancer. 2017l;69:746-51.<\/li>
                    93. Yen HJ, Chen SH, Chang TY, Yang CP, Lin DT, Hung IJ, Lin\nKH, Chen JS, Hsiao CC, Chang TT, Chang TK, Peng CT, Lin MT, Jaing TH, Liu HC,\nJou ST, Lu MY, Cheng CN, Sheen JM, Chiou SS, Hung GY, Wu KH<\/strong>, Yeh TC, Wang SC, Chen RL, Chang HH, Yang YL, Chen SH,\nCheng SN, Chang YH, Chen BW, Hsieh YL, Huang FL, Ho WL, Wang JL, Chang CY, Chao\nYH, Lin PC, Chen YC, Liao YM, Lin TH, Shih LY, Liang DC. Pediatric acute\nlymphoblastic leukemia with t(1;19)\/TCF3-PBX1 in Taiwan. Pediatr Blood Cancer.\n2017;64:e26557.<\/li>
                    94. Chao YH, Wu KH<\/strong>,\nLin CW, Yang SF, Chao WR, Peng CT, Wu HP. PG2, a botanically derived drug\nextracted from Astragalus membranaceus, promotes proliferation and\nimmunosuppression of umbilical cord-derived mesenchymal stem cells. J\nEthnopharmacol. 2017;207:184-91. <\/li>
                    95. Chao YH, Chang YC, Wu HP, Peng CT, Weng TF, Wu KH*<\/sup><\/strong>. Everolimus\nfor pediatric patients with acute graft-versus-host disease after hematopoietic\nstem cell transplantation: A pilot study. Medicine (Baltimore). 2017;96:e8464. (*corresponding author)<\/li>
                    96. Chao YH, Lin CW, Pan HH, Yang SF, Weng TF, Peng CT, Wu KH*<\/sup><\/strong>. Increased\napoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal\nstem cells in severe aplastic anemia. Pediatr Blood Cancer. 2018; e27247. (*corresponding author) <\/li>
                    97. Yeh TC, Liang DC, Hou JY, Jaing TH, Lin DT, Yang CP, Peng\nCT, Hung IJ, Lin KH, Hsiao CC, Jou ST, Chiou SS, Chen JS, Wang SC, Chang TK, Wu KH<\/strong>, Sheen JM, Yen HJ, Chen\nSH, Lu MY, Li MJ, Chang TT, Huang TH, Chang YH, Chen SH, Yang YL, Chang HH,\nChen BW, Lin PC, Cheng CN, Chao YH, Yang SH, Chao YY, Liu HC. Treatment of\nchildhood acute lymphoblastic leukemia with delayed first intrathecal therapy\nand omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002\nstudy. Cancer. 2018;124:4538-4547. <\/li>
                    98. Lin CH, Chen X, Wu CC, Wu KH<\/strong>, Song TS, Weng TF, Hsieh YW, Peng CT. Therapeutic\nmechanism of combined oral chelation therapy to maximize efficacy of iron\nremoval in transfusion-dependent thalassemia major – a pilot study. Expert Rev\nHematol. 2019;12:265-272. <\/li>
                    99. Wang HH, Liao LN, Chang CW, Chang YC, Wu KH<\/strong>, Ko JL. The alteration of\nferritin and transferrin saturation under body mass index and blood pressure in\nfirst-time and regular male blood donors in Taiwan. Medicine (Baltimore).\n2019;98:e15854.<\/li>
                    100. Chen SH, Chen JS, Jou ST, Wu KH<\/strong>, Hung IJ, Sheen JM, Lu MY, Chen BW, Jaing TH, Wang SC,\nLin MT, Chang TK, Liu HC, Yang CP. Outcome and prognosis of anaplastic large\ncell lymphoma in children: a report from the Taiwan Pediatric Oncology Group.\nLeuk Lymphoma. 2019;60:1942-1949. <\/li>
                    101. Chen CH, Wu KH<\/strong>,\nChao YH, Weng DF, Chang JS, Lin CH. Clinical manifestation of pediatric\nmediastinal tumors, a single center experience. Medicine (Baltimore). 2019;98:e16732.<\/li>
                    102. Chao YH, Wu KH<\/strong>.\nTransfusion-related immunomodulation in pediatric patients. Pediatr Neonatol.\n2019;60:483-484. <\/li>
                    103. Yu CH, Chang WT, Jou ST, Lin TK, Chang YH, Lin CY, Lin\nKH, Lu MY, Chen SH, Wu KH<\/strong>,\nWang SC, Chang HH, Su YN, Hung CC, Lin DT, Chen HY, Yang YL. TP53 alterations\nin relapsed childhood acute lymphoblastic leukemia. Cancer Sci. 2020;111:229-238.<\/li>
                    104. Wu KH<\/strong>, Cheng CC, Li JP, Weng TF, Yang SF, Pan HH, Chao YH.\nToll-like receptor signalling associated with immunomodulation of umbilical\ncord\u2013derived mesenchymal stem cells in mice with systemic lupus erythematosus.\nLupus. 2020;29:165-175. <\/li>
                    105. Hsia NY, Lin CJ, Lin HJ, Wu KH<\/strong>. Foveal photoreceptors loss and then recovery after\ntreatment in a chronic myelogenous leukemia patient. Pediatr Hematol Oncol.\n2020;37:545-548.<\/li>
                    106. Yu CH, Lin TK, Jou ST, Lin CY, Lin KH, Lu MY, Chen SH,\nCheng CN, Wu KH<\/strong>, Wang SC,\nChang HH, Li MJ, Ni YL, Su YN, Lin DT, Chen HY, Harrison CJ, Hung CC, Lin SW,\nYang YL. MLPA and DNA index improve the molecular diagnosis of childhood B-cell\nacute lymphoblastic leukemia. Sci Rep. 2020;10:11501.<\/li>
                    107. Yu SL, Zhang H, Ho BC, Yu CH, Chang CC, Hsu YC, Ni YL,\nLin KH, Jou ST, Lu MY, Chen SH, Wu KH<\/strong>,\nWang SC, Chang HH, Pui CH, Yang JJ, Zhang J, Lin DT, Lin SW, Ma X, Yang YL.\nFPGS relapse-specific mutations in relapsed childhood acute lymphoblastic\nleukemia. Sci Rep. 2020;10:12074.<\/li>
                    108. Chuang TY, Li JP, Weng TF, Wu KH<\/strong>, Chao YH. Combined chelation with high-dose\ndeferiprone and deferoxamine to improve survival and restore cardiac function\neffectively in patients with transfusion-dependent thalassemia presenting\nsevere cardiac complications. Ann Hematol. 2020 Jul 31. in press<\/li><\/ol>\n\n\n\n

                      \u570b\u969b\u77e5\u540d<\/strong>SCI<\/strong>\u91ab\u5b78\u671f\u520a\u8ad6\u6587\u5be9\u7a3f\u5b78\u8005<\/strong>(reviewer): <\/strong><\/p>\n\n\n\n

                      1. Pediatrics<\/li>
                      2. Cell\ntransplantation<\/li>
                      3. Transplantation<\/li>
                      4. Annals of\nHematology<\/li>
                      5. Stem Cells\nInternational, Acta Haematologica<\/li>
                      6. Cell Biochemistry\nand Biophysics<\/li>
                      7. Journal of the\nChinese Medical Association<\/li>
                      8. Mycopathologia<\/li>
                      9. Journal of the\nFormosan Medical Association<\/li>
                      10. Pediatrics and\nNeonatology.<\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"

                        \u5deb\u5eb7\u7199\u91ab\u5e2b (\u65bc4\u6708\u4efd\u65bc\u672c\u9662\u670d\u52d9) \u00a0 \u73fe\u4efb \u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u526f\u9662\u9577 \u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u91ab\u5b78\u7cfb \u6559\u6388 \u53f0\u7063\u8840\u6db2 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7991","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/posts\/7991"}],"collection":[{"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7991"}],"version-history":[{"count":5,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/posts\/7991\/revisions"}],"predecessor-version":[{"id":18052,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=\/wp\/v2\/posts\/7991\/revisions\/18052"}],"wp:attachment":[{"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/csh\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}